文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > Management of Chinese patients with type 2 diabetes 1998-2006
侵权投诉

Management of Chinese patients with type 2 diabetes 1998-2006

中国2006年血糖控制现状

Curr Med Res Opin Downloaded from informahealthcare.com by Chinese Academy Of Medical Science on 07/01/10For personal use only.

thetoptencountrieswiththeheaviestdiabetesbur-dens2.Type2diabeteshasbeenamajorhealthconcernandposesaseriouschallengetopatientsandhealthcarepractitionerstopreventandcontrolthisdisease.Diabetesawarenessandeducationintype2diabetespatientsandclinicalpractitionersinChinaareimperative.

Astype2diabetesprogresses,theinitiationoforalantidiabeticdrugs(OADs)orinsulintherapyisneededtocontrolglucoselevels,improvemetabolicdisordersanddelaydiseasedeterioration3.TheDiabcaresurveysweredesignedtodescribeandinvestigatediabetescon-trol,managementandcomplicationstatusinChinesepatientswithdiabetes.TheDiabcaresurveyswerecollaborativestudiesbetweenNovoNordiskandtheChineseDiabetesSociety(CDS).Thepurposeofthestudieswastofollowupdataondemographics,glycaemiccontrol,complicationsstatusandtreatmentregimensamongChinesepatientswithtype2diabetes.

Patientsandmethods

AllpatientswhoparticipatedintheDiabcarestudiessignedwritteninformedconsentbeforecompletingthesurveys.ThestudieswereperformedinaccordancewiththeDeclarationofHelsinki4andwereapprovedbythehumanresearchethicscommitteeineachparti-cipatinghospitalorclinic.

Thestudypopulationincludedallpatientswithtype2diabeteswhohadbeenregisteredatthediabetesclinicfordiabetesmanagementforatleast12months.Thediabetesclinicwasdefinedasanyclinicthathadmorethan100diabeticpatientspermonth(patientswhohadperiodicvisitswithcompletemedi-calrecords).TheselecteddiabetesclinicswereevenlydistributedthroughoutChinaonageographicalbasis,thereforethestudypopulationwasrepresentativeofthediabetespopulationinChina.DiabetesclinicswerelocatedthroughoutChina,andincludedurbanareasandinnercities.Thestudynotonlyincludedmoderncities(Beijing,ShanghaiandGuangzhou),butalsosmallcitiesinruralareas(suchasMianyang,LiuzhouandHaerbin).Subjectswereenrolledintheorderthattheyvisitedtheclinics.Acertainnumberofpatients( 10)wereconsecutivelyrecruitedateachparticipatingcliniceachday.

Datawerecollectedretrospectivelybyreviewingpatientmedicalrecords,aswellasinterviewsandlaboratoryassessments.DataCollectionForms(DCFs)wereusedtocollectinformationonpatientdemography,cardiovascularriskfactors,renal

*Bio-RadVARIANT,Bio-RadLaboratories,Hercules,CA,USA

function,eye,footandseverelatediabetescomplica-tions,glycaemiccontrolandclassificationofinterven-tionsreceived.Thediagnosisoftype2diabeteswasbasedonWorldHealthOrganization(WHO)cri-teria5.Thedefinitionsofdiabetescomplications(includingeye,footandothercomplications)werebasedonnationalstandards6.Neovascularisation,ret-inaldetachment,andretinalhaemorrhagewereincludedasanadvanceddiabeteseyedisease,butnotphotocoagulationwithcorrectedvision56/36(asthiswasincludedinthelegalblindnessanalysis).Thecri-teriaformicroalbuminuriawere0–199mg/min,30–299mg/24hor30–299mg/mg,oramicroalbumi-nuria/creatinineratioof2.5–25mg/mol(male),3.5–25mg/mol(female)7.Thelatestlaboratoryresultsandclinicalexaminationsperformedateachlocalcentrewithinthe12monthsaftertherecruitmentvisitwereused.Inaddition,bothqualityoflifeandself-managementthatcouldbeimprovedwithpsycho-logicaltreatment,asidentifiedbytheDiabetesAttitudes,WishesandNeeds(DAWN)studywereused8.Psychologicalquestionnairesdevelopedin2003inadditiontotheobservationalDiabcarestudiesondiabetescontrolinAsiandiabetespatientscaredforbyspecialists/endocrinologistswereusedinDiabcare2006.A5-itemWHO-5questionnaire9,10wasusedtoassesspsychologicalwell-beinginpatientswithtype2diabetesandthe9-itemDAWN-modifiedquestion-naire11,12–14wasusedforassessmentofqualityoflifeinthetargetpopulation.

FingercapillarybloodsampleswerecollectedduringtheenrolmentvisitusingaBio-RadHbA1csamplepre-parationkit.Allsampleswerestoredat2–8 CandHbA1canalyseswereperformedatthecentrallabora-toryofEndocrinologyandMetabolismDiseaseintheGeneralPLAhospital(Beijing,China)byauto-matichigh-pressureliquidchromatography(Bio-RadVARIANT*).Thenon-diabetesnormalrange(maleandfemale)forthisassayisfrom4.6%to6.0%.Theintra-assaycoefficientofvariation(CV)rangesfrom0.43%to1.18%andinter-assayCVrangesfrom2.8%to3.3%.

ThecontinuousvariableswereanalysedbyStudent’st-test.Iftheoriginaldatawerenotnormallydistributed,atransformationwasusedtoachievenor-mality;ifthiswasnotappropriate,anon-parametertestwasused.Thechi-squaretestwasusedtocomparecategoricalvariables.Allstatisticalanalyseswereper-formedbyNovoNordisk(China)inBeijing.Alldatawereuploadedintoadatabase(EPIdata),thentabu-latedandanalysedusingSAS(version9.1,SASInstituteInc.,Cary,USA).

40DiabetescareinChinesepatientswithtype2diabetes

ß2009InformaUKLtd-CurrMedResOpin2009;25(1)

上一页第2页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email